Laparoscopic sleeve gastrectomy for a two-and half year old morbidly obese child

Mohammed Al Mohaidly1, Ahmed Suliman, Horia Malawi

  • 1Department of Pediatric Surgery, Prince Sultan Military Medical City, Riyadh 11159, Saudi Arabia.

Insights

Laparoscopic sleeve gastrectomy (LSG) is safe and effective for treating severe childhood obesity, even in very young children. This bariatric surgery significantly reduced BMI and improved sleep apnea in a 2.5-year-old patient.

Area of Science:

  • Pediatric Surgery
  • Bariatric Surgery
  • Obesity Management

Background:

  • Laparoscopic sleeve gastrectomy (LSG) is a recognized bariatric surgery for obesity.
  • LSG has shown effectiveness in pediatric cases but has not been documented in very young children.

Purpose of the Study:

  • To report the safety and efficacy of LSG in a very young child with morbid obesity.
  • To evaluate the impact of LSG on associated comorbidities like obstructive sleep apnea and leg bowing.

Main Methods:

  • Case report of a 2.5-year-old child with morbid obesity undergoing LSG.
  • Pre-operative investigations excluded genetic or hereditary causes of obesity.
  • Post-operative follow-up for two years, monitoring BMI and comorbidities.

Main Results:

  • LSG was well-tolerated with no complications.
  • Significant reduction in obstructive sleep apnea within two months post-surgery.
  • Drastic reduction in Body Mass Index (BMI) from 41.1 to 24 kg/m² at 24 months post-surgery.

Conclusions:

  • LSG is a safe and effective option for severe obesity in children under three years old.
  • This case represents the youngest child reported to undergo LSG.
  • Further studies are essential to monitor long-term growth and development in pediatric LSG patients.
Abstract

Related Concept Videos